Showing results (341-350 of 2,504) with videos related to
Sort By:
Pageof 251
Endocrine-Related Cancer|November 18, 2008
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptorKamilla Malinowska, Hannes Neuwirt, Ilaria T Cavarretta, et al.Endocrine-Related Cancer|February 17, 2009
Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomasP S H Soon, A J Gill, D E Benn, et al.Endocrine-Related Cancer|September 17, 2009
Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomasF Cetani, E Pardi, C Banti, et al.Endocrine-Related Cancer|September 10, 2009
Reproductive disturbances in multiple neuroendocrine tumor syndromesAristides Lytras, George TolisEndocrine-Related Cancer|September 4, 2009
Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC-FFCD 9710Laetitia Dahan, Frank Bonnetain, Philippe Rougier, et al.Endocrine-Related Cancer|August 23, 2005
Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancerR Duncan, M J Vicent, F Greco, et al.Endocrine-Related Cancer|August 23, 2005
Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivationLesley-Ann Martin, Ian Farmer, Stephen R D Johnston, et al.Endocrine-Related Cancer|August 23, 2005
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancerJ M Gee, J F Robertson, E Gutteridge, et al.Endocrine-Related Cancer|January 30, 2007
Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalkSuleiman Massarweh, Rachel SchiffEndocrine-Related Cancer|January 30, 2007
Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancerStephen Hiscox, L Morgan, Tim Green, et al.Pageof 251